Biomedical subjects
Publications and source records attributed to K T Yue.
We report the Raman spectrum of liver alcohol dehydrogenase in solution. The enzyme's secondary structure as determined from an examination of the Raman bands is slightly different than that found in crystals by X-ray diffraction.
The recombination after flash photolysis of dioxygen and carbon monoxide with sperm whale myoglobin (Mb), and separated beta chains of human hemoglobin (beta A) and hemoglobin Zürich (beta ZH), has been studied as a function of pH and temperature from 300 to 60 K. At physiological temperatures, a preequilibrium is established between the ligand molecules in the solvent and in the heme pocket. The ligand in the pocket binds to the heme iron by overcoming a barrier at the heme. The association rate is controlled by this final binding step. The association rate of CO to Mb and beta A is modulated by a single titratable group with a pK at 300 K of 5.7. The binding of CO to beta ZH, in which the distal histidine is replaced by arginine, does not depend on pH. Oxygen recombination is independent of pH in all three proteins. Comparison of the binding of CO at 300 K and at low temperatures shows that pH does not affect the preequilibrium but changes the barrier height at the heme. The pH dependence and the difference between O2 and CO binding can be explained by a charge-dipole interaction between the distal histidine and CO.
The binding of carbon monoxide to ferrous chloroperoxidase in the pH range 4-6.5 is influenced by a titratable group on the enzyme having a pKA of 5.5 +/- 0.2 at 20 degrees C. The basic form of the enzyme reacts much faster with carbon monoxide than does the protonated form of the enzyme. The delta H degrees for the ionization of the functional group in the enzyme involved in carbon monoxide binding is about 8 kcal mol-1, and the delta S degrees is approximately 1 cal mol-1 K-1. These pKA and delta H degrees values suggest that this functional group is an imidazole ring associated with a histidine residue situated at the active site of the enzyme. The rates of the reaction for the formation and dissociation of the complex suggest that this histidine residue is not directly liganded to the iron atom of the heme prosthetic group. The relatively good agreement between the various kinetic approaches with several methods of experimentation, data collection, and data analysis lends strength to a proposed model in which the histidine occupies a distal site close to the sixth axial ligand position of the heme iron atom.
We have studied the infrared spectra of the bound and photodissociated states of Mb-12CO and Mb-13CO from 5.2 to 300 K. The absorbance peaks seen between 1800 and 2200 cm-1 correspond to CO stretching vibrations. In the bound state of Mb-12CO, the known lines A0 at 1969, A1 at 1945, and A2 at 1927 cm-1, have center frequencies, widths, and absorbances that are independent of temperature between 5.2 and 160 K. Above 160 K, A2 gradually shifts to 1933 cm-1. The low-temperature photodissociated state (Mb) shows three lines (B0, B1, B2) at 2144, 2131, and 2119 cm-1 for 12CO. The absorbances of the three lines depend on temperature. B0 is tentatively assigned to free CO in the heme pocket and B1 and B2, to CO weakly bound to the heme or heme pocket wall. The data are consistent with a model in which photodissociation of MbCO leads to B1 and B2. B2 decays thermally to B1 above 13 K; rebinding to A occurs from B1. The barriers between B2 and B1 and between B1 and A are described by activation enthalpy spectra. Heme and the central metal atom in state Mb have near-infrared, EPR, and Mössbauer spectra that differ slightly from those of deoxyMb. The observation of essentially free CO in state B implies that the difference between Mb and deoxyMb is not due to an interaction of the flashed-off ligand with the protein but is caused by an incomplete relaxation of the protein structure at low temperatures.
Degradation of 14C-ADP in human platelet-rich and platelet-poor plasmas was studied. Three procedures were tested to determine which method was most effective in "stopping" enzyme reactions. One involved the immediate addition of perchloric acid to the reaction mixture at the end of the incubation period. Another involved "stopping" enzyme reactions at 0 degree C for about 20 min before the addition of perchloric acid. The third involved adding EDTA (10 mM final concentration) to "stop" the reactions at the end of incubation. The protein-free extracts from the plasmas were processed for adenine nucleotide assays by thin-layer chromatography. Addition of perchoric acid was most effective. Low temperature did not stop degradation of 14C-ADP in plasma even in the presence of EDTA. 14C-ADP was converted primarily to 14C-AMP. ADPase activity was the same in platelet-rich and platelet-poor plasmas. We conclude that the addition of EDTA and the cooling of plasma did not completely stop the enzymic degradation of ADP.
Explore the source record for details and available documents.
Proteins are dynamic systems. Recent evidence demonstrates that they exist in a large number of conformational substates and can continuously move from one substate to another; motion of a small ligand inside a protein may be possible only through these conformational fluctuations. To test this idea, we study with flash photolysis the binding of CO to protoheme and O2 and CO to myoglobin in many different solvents. The standard evaluation of such experiments yields information only about the protein-solvent system. A novel approach is presented which permits conclusions concerning the protein: Data from all solvents are considered together, and the rates for transitions of the ligand over various barriers are studied as a function of temperature for fixed solvent viscosities. Results show that over a wide range in viscosity the transition rates in heme-CO are inversely proportional to the solvent viscosity and can consequently be described by the Kramers equation. The rates of O2 and CO in myoglobin also depend on the solvent viscosity and are most sensitive to the solvent at the lowest viscosity. Viscosity influences protein reactions even in aqueous solutions. The data dan be interpreted by a dynamic model in which transitions into and inside myoglobin are governed by fluctuations between conformational substates corresponding to closed and open pathways. Ligand motion thus is mainly controlled by gates and not by static potential barriers. Some characteristic parameters for the substates are determined, and they agree approximately with similar parameters found in Mössbauer experiments. As expected, the barrier parameters evaluated in the novel approach deviate markedly from the ones obtained by the conventional procedure. Comparison with model calculations or basic theories will be meaningful only with the new evaluation, and the method may be essential for many or possibly all biochemical reactions.
Explore the source record for details and available documents.
The replacement reaction of myoglobin (Mb), MbCO + O2 leads to MbO2 + CO leads to MbCO + O2, has been studied with flash photolysis in the temperature range from 140 to 320 K and the time range from 2 mus to 200 s. In a fraction of the Mb, the photodissociated CO remains within the protein; rebinding is not affected by the presence of O2 and occurs with rates that are identical with the ones observed earlier in solvents containing only CO. In the remaining fraction CO migrates into the solvent and Mb combines preferentially with oxygen. The rate of the subsequent replacement of O2 by CO permits calculation of the oxygen dissociation rate ko2; ko2 has been determined from 260 to 320 K. The measurements support a multibarrier model.
Using a turbidimetric technique, we determined 1.7 micrometer adenosine diphosphate--induced platelet aggregation and disaggregation at 37 degrees C in the platelet-rich plasmas of two groups of men with coronary artery disease. Eleven men were nondiabetic and 11 had adult-onset diabetes mellitus without retinopathy. There were no significant differences (P greater than .05) between diabetics and nondiabetics of the following variables: age, platelet count in platelet-rich plasma, first and second phases of platelet aggregation, maximum extent of aggregation, and percent disaggregation at three minutes after maximum aggregation occurred. Although the mean adenosine diphosphate--induced platelet aggregation in the platelet-rich plasmas of adult-onset diabetic men with coronary artery disease and no retinopathy was not enhanced, and the mean rate of disaggregation was not reduced, when compared with nondiabetic men with coronary artery disease or with healthy men; a slow rate of platelet disaggregation (less than 10%) occurred more frequently in the platelet-rich plasmas of men with coronary artery disease.
Suspecting that platelet thromboemboli could play a role in the pathogenesis of myocardial ischemia, we did a random-order, double-blind, crossover study of the effect of the platelet aggregation inhibitor, aspirin, on treadmill exercise-induced angina in 13 men with coronary artery disease. Although collagen-induced platelet aggregation and the second phase of adenosine diphosphate (ADP)-induced platelet aggregation were significantly decreased and the rate of disaggregation of ADP-induced platelet aggregates was significantly increased after 650 mg aspirin in buffered solution, there was no delay in onset of exercise-induced angina, change in heart rate-blood pressure product at onset of angina, or change in S-T segment depression at onset of angina. Regardless of whether the patients had received placebo or aspirin on the preceding day, treadmill exercise until angina was followed by no changes in platelet aggregation or disaggregation, platelet count in blood or platelet-rich plasma, or of the plasma concentration of nonesterified fatty acids.
Aspirin is a potent inhibitor of the platelet release reaction and the accompanying second phase of platelet aggregation. The platelet release reaction is an active, energy-dependent process which appears to require ATP. Eight men ingested 0.32 gm of aspirin daily for 7 days. Although the second phase of 1.7 micron ADP-induced platelet aggregation was absent after aspirin ingestion, the "ecto-ATPase" activities of washed human platelet suspensions were not significantly different before and after ingestion of aspirin. This suggests that the effect of aspirin on the second phase of platelet aggregation is not mediated through inhibition of "ecto-ATPase".
Explore the source record for details and available documents.
Using fast flash photolysis, we have measured the binding of CO to carboxymethylated cytochrome c and to heme c octapeptide as a function of temperature (5 degrees-350 degreesK) over an extended time range (100 ns(-1) ks). Experiments used a microsecond dye laser (lambda = 540 nm), and a mode-locked frequency-doubled Nd-glass laser (lambda = 530 nm). At low temperatures (5 degrees-120 degreesK) the rebinding exhibits two components. The slower component (I) is nonexponential in time and has an optical spectrum corresponding to rebiding from an S = 2, CO-free deoxy state. The fast component (I*) is exponential in time with a lifetime shorter than 10 mus and an optical spectrum different from the slow component. In myoglobin and the separated alpha and beta chains of hemoglobin, only process I is visible. The optical absorption spectrum of I* and its time dependence suggest that it may correspond to recombination from an excited state in which the iron has not yet moved out of the heme plane. The temperature dependences of both processes have been measured. Both occur via quantum mechanical tunneling at the lowest temperatures and via over-the-barrier motion at higher temperatures.
Our previous work has shown that the addition of diphenhydramine hydrochloride to platelet-rich plasma is capable of causing disaggregation of platelet aggregates already induced by adenosine diphosphate as well as of inhibiting platelet aggregation when added prior to the aggregating agent. This led us to attempt to prevent arterial thrombosis in a canine experimental model. Ten dogs received an injection of diphenhydramine (approximately 3 mg/kg of body-weight) into the right common femoral artery 1 cm proximal to the proximal end of a 2 cm endarterectomy immediately after closure of the endarterectomy site and prior to performing an endarterectomy of the other common femoral and both common carotid arteries. The dogs which received diphenhydramine were compared with ten control dogs and found to have no protection against thrombosis at the sites of endarterectomy after 4 and 24 hours.
It has been previously shown and confirmed in the present investigation that the disaggregation of adenosine diphosphate (ADP)-induced platelet aggregates occurs at a slow rate more frequently in the platelet-rich plasma (PRP) of men with coronary artery disease. ADP-induced platelet aggregation was studied in the citrated PRP of 32 men (21 with and 11 without coronary artery disease) to determine the relation between release of heparin neutralizing activity (HNA) from platelets and the rate of platelet diaggregation. Each of the five PRP with slow (less than 10 per cent) disaggregation were from men with coronary artery disease. Platelets from these five PRP released from 34 to 51 per cent of their content of HNA during ADP-induced aggregation in contrast to the 27 PRP with more rapid disaggregation, only three of which had a detectable release of HNA. Of the latter 27 PRP, 21 had a second phase of aggregation which usually reached a peak of light transmission less than that of the first phase. These data are consistent with (but do not prove) the hypothesis that HNA released during aggreation may be one of the factors tending to prevent disaggregation of ADP-induced platelet aggregates.
Explore the source record for details and available documents.
Explore the source record for details and available documents.